- Cleanaway has entered into a Scheme Implementation Deed to acquire 100% of the shares on issue in Toxfree for $3.425 per share in cash (“Acquisition Price”), representing an equity value of $671 million and an enterprise value of $831 million1 (“Acquisition”)
- Strategically compelling acquisition that strengthens Cleanaway’s existing operating segments, further improves operating leverage and delivers Cleanaway a leading position in the attractive medical waste segment
